FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Avonmore Capital Buyback and Zydus Lifesciences Buyback.
Avonmore Capital Buyback is a Tender Offer buyback proposed to list at BSE, NSE while Zydus Lifesciences Buyback is a Tender Offer proposed to list at BSE, NSE.
Avonmore Capital & Management Services Limited | Zydus Lifesciences Limited | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Logo | ||||||||||||||
Type of Buyback | Tender Offer | Tender Offer | ||||||||||||
Listing At | BSE, NSE | BSE, NSE | ||||||||||||
Face Value | ₹10 per share | ₹1 per share | ||||||||||||
Buyback Price | ₹95 per share | ₹650 per share | ||||||||||||
Issue Size | 9,17,680 shares | 1,15,38,461 shares | ||||||||||||
Issue Size (Amount) | ₹8.72 Crores | ₹750.00 Crores | ||||||||||||
Buyback Ratio |
|
|
||||||||||||
Registrar | Beetal Financial & Computer Services (P) Limited | Link Intime India Private Ltd | ||||||||||||
Lead Managers | Corporate Capitalventures Pvt Ltd | ICICI Securities Limited | ||||||||||||
Necessity of the buyback | The buyback is being undertaken for the following reasons: 1. The Buyback will help the company to distribute surplus cash to its shareholders holding Equity shares broadly to the proportion of their shareholding, thereby, enhancing the overall return to shareholders. 2. The Buyback would help in improving its return on equity, by reducing the equity base, thereby leading to a long term increase in shareholders' value. |
The buyback is being undertaken for the following reason: 1. The Buyback will help the Company to distribute a part of the surplus cash to its shareholders holding Equity Shares thereby, optimizing returns to the shareholders and enhancing the overall shareholders' value in longer term and improving the return on equity. |
Avonmore Capital Buyback and Zydus Lifesciences Buyback buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Avonmore Capital Buyback Buyback record date is Jun 15, 2022. Zydus Lifesciences Buyback Buyback record date is Jun 02, 2022.
Avonmore Capital & Management Services Limited | Zydus Lifesciences Limited | |
---|---|---|
Record Date | Jun 15, 2022 | Jun 02, 2022 |
Offer Open Date | Jul 04, 2022 | Jun 23, 2022 |
Offer Closure Date | Jul 15, 2022 | Jul 06, 2022 |
Last date for receipt of tender forms | Jul 18, 2022 | Jul 06, 2022 |
Finalisation of buyback | Jul 22, 2022 | Jul 14, 2022 |
Last Date for settlment of bids | Jul 25, 2022 | Jul 15, 2022 |
Last Date for extinguishment of shares | Aug 01, 2022 | Jul 22, 2022 |
Comparison of Avonmore Capital Buyback and Zydus Lifesciences Buyback financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.
Avonmore Capital & Management Services Limited | Zydus Lifesciences Limited | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||
Stock price at BSE | Stock price at BSE (in preceding 3 months)
|
Stock price at BSE (in preceding 3 months)
|
||||||||||||||||||||||||||||||||||||||||||||
Stock price at NSE | Stock price at NSE (in preceding 3 months)
|
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|